Georg Bjarnason
Overview
Explore the profile of Georg Bjarnason including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Nayan M, Jalali S, Kapoor A, Finelli A, So A, Rendon R, et al.
Urol Oncol
. 2019 Jul;
37(9):576.e11-576.e16.
PMID: 31285115
Introduction: Diabetes has been associated with worse survival outcomes in various malignancies; however, there are conflicting data in kidney cancer. Determining whether diabetes is associated with survival in kidney cancer...
12.
Shi Y, Wang G, Muhowski E, McCaw L, Wang C, Bjarnason G, et al.
Leukemia
. 2019 Jan;
33(7):1650-1662.
PMID: 30696950
Glucocorticoid (GC) receptor (GR) phosphorylation and signature genes were studied in chronic lymphocytic leukemia (CLL) cells to help place GCs within modern treatment algorithms. In contrast to normal B and...
13.
Saleeb R, Farag M, Lichner Z, Brimo F, Bartlett J, Bjarnason G, et al.
Mol Oncol
. 2018 Jun;
12(10):1673-1688.
PMID: 29896907
Papillary renal cell carcinoma (PRCC) is the most common nonclear cell RCCs and is known to comprise two histological subtypes. PRCC2 is more aggressive and is molecularly distinct from the...
14.
Garbens A, Wallis C, Bjarnason G, Kulkarni G, Nathens A, Nam R, et al.
Can Urol Assoc J
. 2017 Oct;
11(11):E414-E420.
PMID: 29072562
Introduction: We sought to examine the relationship between preoperative platelet to white blood cell ratio (PLT/WBC), a hematological marker of the systemic inflammatory response, and postoperative infectious complications following radical...
15.
Saleeb R, Brimo F, Farag M, Rompre-Brodeur A, Rotondo F, Beharry V, et al.
Am J Surg Pathol
. 2017 Oct;
41(12):1618-1629.
PMID: 28984673
Papillary renal cell carcinoma (PRCC) has 2 histologic subtypes. Almost half of the cases fail to meet all morphologic criteria for either type, hence are characterized as PRCC not otherwise...
16.
Wallis C, Downes M, Bjarnason G, Satkunasivam R
BMJ Case Rep
. 2016 Aug;
2016.
PMID: 27507690
The identification of small renal masses is increasing. Active surveillance is a guideline-approved management strategy for select patients with small renal masses. Metastases during the observation of small renal masses...
17.
Wallis C, Bjarnason G, Byrne J, Cheung D, Hoffman A, Kulkarni G, et al.
Urology
. 2016 Jun;
95:95-102.
PMID: 27292566
Objective: To determine the effect of disseminated cancer on perioperative outcomes following radical nephrectomy. Methods: We conducted a retrospective cohort study of patients undergoing radical nephrectomy for kidney cancer from...
18.
North S, Basappa N, Basiuk J, Bjarnason G, Breau R, Canil C, et al.
Can Urol Assoc J
. 2015 Jul;
9(5-6):164-70.
PMID: 26225164
No abstract available.
19.
North S, Basappa N, Bjarnason G, Blais N, Canil C, Heng D, et al.
Can Urol Assoc J
. 2013 Sep;
7(7-8):238-43.
PMID: 24032057
No abstract available.
20.
Al-Marrawi M, Rini B, Harshman L, Bjarnason G, Wood L, Vaishampayan U, et al.
Target Oncol
. 2013 Jan;
8(3):203-209.
PMID: 23300029
There are many active drugs to treat metastatic renal cell carcinoma (mRCC) patients who progress through their first-line vascular endothelial growth factor (VEGF) inhibitor. Many clinicians choose a second-line VEGF...